Publications by authors named "Carol Cheli"

Claim this Profile
C
Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot study.
Herbert Lepor, Carol D Cheli, Robert P Thiel, Samir S Taneja, Juliana Laze

BJU Int· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fifth-generation digital immunoassay for prostate-specific antigen by single molecule array technology.
David H Wilson, David W Hanlon, Gail K Provuncher, Lei Chang, Linan Song, Carol D Cheli

Clin Chem· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complexed prostate-specific antigen for the diagnosis of biochemical recurrence after radical prostatectomy.
J Kellogg Parsons, Alan W Partin, Bruce Trock, Debra J Bruzek, Carol Cheli

BJU Int· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The detection and potential economic value of complexed prostate specific antigen as a first line test.
R Joseph Babaian, Yoshio Naya, Carol Cheli, Herbert A Fritsche

J Urol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.
Francisco J Esteva, Carol D Cheli, Herbert Fritsche, Monica Fornier, Dennis Slamon

Breast Cancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum levels of shed Her2/neu protein in men with prostate cancer correlate with disease progression.
Iman Osman, Maryann Mikhail, Brian Shuch, Megan Clute, Carol D Cheli

J Urol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA.
J Kellogg Parsons, Michael K Brawer, Carol D Cheli, Alan W Partin, Robert Djavan

BJU Int· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer.
Yoshio Naya, Herbert A Fritsche, Carol D Cheli, Thomas A Stamey, Georg Bartsch

Urology· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complexed prostate specific antigen improves specificity for prostate cancer detection: results of a prospective multicenter clinical trial.
Alan W Partin, Michael K Brawer, Georg Bartsch, Wolfgang Horninger, Samir S Taneja, Carol D Cheli

J Urol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age on complexed PSA levels in men with total PSA levels of up to 20 ng/mL.
Andreas P Berger, Carol Cheli, Ronald Levine, Helmut Klocker, Georg Bartsch

Urology· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar age-specific PSA, complexed PSA, and percent cPSA levels among African-American and white men of southern Louisiana. Prostate-specific antigen.
Benjamin Martin, Carol Cheli, Steven Pollard, Jerry Sullivan, Jack Goodman

Urology· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the clinical performance of equimolar- and skewed-response total prostate-specific antigen assays versus complexed and free PSA assays and their ratios in discriminating between benign prostatic hyperplasia and prostate cancer.
Frank H Wians, Carol D Cheli, Jody A Balko, Debra J Bruzek, Daniel W Chan

Clin Chim Acta· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis.
Samir S Taneja, Elias I Hsu, Carol D Cheli, Paul Walden, Georg Bartsch

Urology· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter.
Wolfgang Horninger, Carol D Cheli, Richard J Babaian, Herbert A Fritsche, Herbert Lepor

Urology· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
Yoshio Naya, Thomas A Stamey, Carol D Cheli, Alan W Partin, Lori J Sokoll

Urology· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-benefit analysis of total, free/total, and complexed prostate-specific antigen for prostate cancer screening.
Lars Ellison, Carol D Cheli, Steven Bright, Robert W Veltri, Alan W Partin

Urology· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-related reference ranges for complexed prostate-specific antigen and complexed/total prostate-specific antigen ratio: results from East Texas Medical Center Cancer Institute screening campaign.
Carol D Cheli, Ronald L Levine, Debora R Cambetas, James D Kolker, Steven B Roberts

Urology· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer.
Koji Okihara, Carol D Cheli, Alan W Partin, Herbert A Fritche, Daniel W Chan

J Urol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis